ACC.22: Medtronic Renal Denervation System Demonstrates Significant BP Reduction Through 3 Years

ACC.22: Medtronic adds to its robust clinical program with long-term data demonstrating the continued blood pressure lowering effect of the Symplicity renal denervation procedure. Also
completes enrollment in the SPYRAL HTN-ON MED trial.

← Previous
Next →
  • Medical Specialists Subscribe
  • Industry Subscribe
  • Privacy Statement
    • Cookie Policy
  • Contact
  • Medical Specialists Subscribe
  • Industry Subscribe
  • Privacy Statement
    • Cookie Policy
  • Contact
  • ADVERTISE
  • ADVERTISE

© 2026 All rights Reserved. Medical Device News Magazine, a Division of PTM Healthcare Marketing, Inc.